87 results on '"Jansz P"'
Search Results
2. Donation After Circulatory Death Heart Transplantation - Withdrawal Practices and Location Matter!
3. Satisfactory Short and Long-Term Outcomes from Careful Selection of Older Donors for Lung Transplantation: An Australian Single-Centre Experience
4. Initial Single Centre Experience with The XVIVO Hypothermic Perfusion System: Outcomes from the First 32 Cases
5. Utilizing All the Tools in the ‘Box’ for Heart Transplantation
6. (398) Favorable Impact of Hypothermic Machine Perfusion (HMP) on Early Renal Outcomes in Patients Undergoing Heart Transplantation Using Prolonged (6-8 Hour) Donor Hearts
7. (1059) Peri-Operative Transfusion Requirements and ICU Length of Stay after Heart Transplantation for Patients with LVADs Anticoagulated with Apixaban - Initial Experience
8. (930) Comparing Lung Donation after Circulatory Death to Donation after Brain Death in a Single Australian Centre
9. (865) Improving Asystolic Warm Ischemic Time Tolerance in Donation after Circulatory Death Donor Hearts
10. Influence of Hypothermic Machine Perfusion (HMP) on Donor Heart Function Following an Ischemic Time of 6-8 Hours
11. (117) Initial Australian Experience with the Xvivo Non-Ischaemic Hypothermic Perfusion Device for Heart Preservation
12. Pushing The Boundaries of Donation After Circulatory Death Heart Transplantation - The Australian Experience
13. Baseline Ventricular Assist Device (VAD) Flow as a Potential Marker of Increased Morbidity and Mortality Risk During Blood Stream Infection (BSIs) in Patients with Fixed Pump Speed
14. Heart Transplantation from Donation After Circulatory Death Donors: An Update on the Australian Experience
15. Exploring the Benefit of Thoracotomy LVAD Implant on Subsequent Sternal Entry for Heart Transplantation
16. Comparing Velocity and Mean Arterial Pressure to Assess Pulsatility in Patients with Continuous Flow Left Ventricular Assist Devices
17. Marginal Cardiac Donors and Transplant Outcomes: An 11-Year Experience
18. Polymicrobial and Multiple Blood Stream Infection Episodes as Risk Factors for On-Pump Mortality in Mechanical Circulatory Support Patients
19. Comparison of Outcomes Following Physician Directed Bolus vs. Strict Infusion Protocol of Tissue Plasminogen Activator for Thrombolytic Treatment of Pump Thrombosis
20. Development of a Donor-Recipient Matching Algorithm for Lung Transplantation in Australia
21. Extracorporeal Membrane Oxygenation for Primary Graft Failure Following Heart Transplantation
22. Bloody Transplants! Impact of Prior Sternotomy on Transfusion Rate in Heart Transplantation
23. Comparing HVAD Inflow Cannula Angle between Median Sternotomy and Thoracotomy
24. Impact of COVID-19 on Lung Transplantation in Australia
25. Anatomical Human Fitting of the Bivacor Total Artificial Heart
26. Outcomes of Patients with Chronic Thromboembolic Pulmonary Hypertension Risk Stratified by a Dedicated Heart Team to Receive Pulmonary Endarectomy or Balloon Pulmonary Angiogiplasty
27. Echocardiographic Outcomes Following Left Ventricular Assist Device or Mitral Valve Repair in Severe Left Ventricular Dilatation with Mitral Regurgitation
28. Vasopressor Requirement in Patients Undergoing Ventricular Assist Device Explant and Heart Transplant
29. Hypertension, Arterial Compliance and LVAD Pump Function
30. Pump Thrombosis, Scratching the Surface
31. First in Man Anatomical Fitting Study of the BiVACOR Total Artificial Heart
32. Unexpected Contribution of Pulsatility to Pump Thrombosis
33. A Study of Infected Drivelines from Ventricular Assist Device Patients: The Presence of Microbial Biofilms and Micro-Gaps in the Driveline Tunnel
34. The Implication of HeartWare HVAD Inflow Cannula Angle on Stroke and Thrombus Rate
35. Acoustic Characterisation of the HeartWare Left Ventricular Assist Device
36. Inspiratory Breath-Hold - A Simple Clinical Intervention to Assess Risk Threshold for Suction Events in Stable LVAD Outpatients
37. Lavare Cycle Does Not Induce Pulsatility in CF-LVAD Patients
38. Frailty Predicts Mortality After Heart Transplantation
39. Evidence for Subclinical, Progressive Outflow Graft Stenosis in Patients With Heartware HVAD
40. Donation After Circulatory Death (DCD) Heart Transplantation in Australia: An Update of Current Practises and Outcomes
41. Reversibility of Fried’s Physical Frailty Domains Post- Ventricular-Assist Device Implantation Among Patients with Advanced Heart Failure
42. Predictive Value of I-CARS for LV Recovery in an Unselected cf-LVAD Cohort
43. Continuous-flow LVAD Therapy: A ‘Forme-fruste’ of Diastolic Heart Failure
44. Rapid Retrieval and Ex Situ Portable Machine Perfusion Allows Successful Cardiac Transplantation with Donor Hearts from Controlled Donation After Circulatory Death
45. Beat-to-Beat Detection of Aortic Valve Opening in Continuous Flow LVAD Patients with Irregular Cardiac Rhythm and with Hemodynamic Maneuvers
46. Outcome After Warm Machine Perfusion (WMP) Recovery of Marginal Brain Dead (MBD) and Donation After Circulatory Death (DCD) Heart Transplantation
47. Apixabanin Mechanical Circulatory Support - Evaluation in a Mock Circulatory Loop with Human Blood
48. Diurnal and Patient Activity Related Determinants of Aortic Valve Opening on Continuous Flow LVAD Support
49. Effect of the Lavare Cycle on Pump Function, Aortic Valve Opening, Autonomic Function and Activity Outcomes in Continuous Flow LVAD Patients
50. Cerebrovascular Events in Patients with Continuous Flow Left Ventricular Assist Devices
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.